157 related articles for article (PubMed ID: 12036913)
21. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
[TBL] [Abstract][Full Text] [Related]
22. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
23. No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.
Rashid MU; Torres D; Zaidi A; Rasheed F; Sultan F; Shakoori AR; Amin A; Hamann U
Breast Cancer Res Treat; 2008 Jan; 107(1):155-6. PubMed ID: 18043900
[No Abstract] [Full Text] [Related]
24. Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
Evans DG; Howell A
Breast Cancer Res; 2004; 6(1):E7. PubMed ID: 14680492
[TBL] [Abstract][Full Text] [Related]
25. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
26. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
28. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
[TBL] [Abstract][Full Text] [Related]
29. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Tołoczko-Grabarek A; Gilbert M; Edler L; Zapatka M; Eils R; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2010 Jan; 119(1):201-11. PubMed ID: 19360465
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
[TBL] [Abstract][Full Text] [Related]
31. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.
Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A
Breast; 2007 Jun; 16(3):280-92. PubMed ID: 17257844
[TBL] [Abstract][Full Text] [Related]
32. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of loss of heterozygosity and microsatellite instability RAD52, RAD54 and RAD54B gene and BRCA1 gene mutation in breast cancer].
Romanowicz-Makowska H; Smolarz B
Pol Merkur Lekarski; 2006 Dec; 21(126):548-50. PubMed ID: 17405295
[TBL] [Abstract][Full Text] [Related]
34. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
Colilla S; Kantoff PW; Neuhausen SL; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Brown M; Weber BL; Rebbeck TR
Carcinogenesis; 2006 Mar; 27(3):599-605. PubMed ID: 16244359
[TBL] [Abstract][Full Text] [Related]
35. Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population.
Jara L; Dubois K; Gaete D; de Mayo T; Ratkevicius N; Bravo T; Margarit S; Blanco R; Gómez F; Waugh E; Peralta O; Reyes JM; Ibáñez G; González-Hormazábal P
Breast Cancer Res Treat; 2010 Aug; 122(3):813-22. PubMed ID: 20054644
[TBL] [Abstract][Full Text] [Related]
36. Association of interleukin-10 gene variation with breast cancer prognosis.
Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
[TBL] [Abstract][Full Text] [Related]
37. Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer.
Romanowicz-Makowska H; Smolarz B; Zadrozny M; Kulig A
Exp Oncol; 2006 Jun; 28(2):156-9. PubMed ID: 16837909
[TBL] [Abstract][Full Text] [Related]
38. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.
Eisinger F; Stoppa-Lyonnet D; Longy M; Kerangueven F; Noguchi T; Bailly C; Vincent-Salomon A; Jacquemier J; Birnbaum D; Sobol H
Cancer Res; 1996 Feb; 56(3):471-4. PubMed ID: 8564955
[TBL] [Abstract][Full Text] [Related]
39. Germline genetic variation, cancer outcome, and pharmacogenetics.
Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G
J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599
[TBL] [Abstract][Full Text] [Related]
40. Tumour diploidy and survival in breast cancer patients with BRCA2 mutations.
Tryggvadottir L; Olafsdottir EJ; Olafsdottir GH; Sigurdsson H; Johannsson OT; Bjorgvinsson E; Alexiusdottir K; Stefansson OA; Agnarsson BA; Narod SA; Eyfjord JE; Jonasson JG
Breast Cancer Res Treat; 2013 Jul; 140(2):375-84. PubMed ID: 23857704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
